• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Traws Pharma, Inc. - Common Stock (NQ:TRAW)

1.410 +0.070 (+5.22%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 80,766
Open 1.340
Bid (Size) 1.350 (100)
Ask (Size) 1.400 (400)
Prev. Close 1.340
Today's Range 1.340 - 1.410
52wk Range 0.9801 - 9.506
Shares Outstanding 5,564,315
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
December 17, 2025
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
Traws Pharma Reports Positive Interim Clinical Data with Ratutrelvir Versus PAXLOVID™, Shows Activity in PAXLOVID-Ineligible COVID-19 Patients
December 17, 2025
From Traws Pharma, Inc.
Via GlobeNewswire

Performance

YTD
+6.0%
+6.0%
1 Month
-34.7%
-34.7%
3 Month
-43.4%
-43.4%
6 Month
-9.0%
-9.0%
1 Year
-84.4%
-84.4%

More News

Read More
News headline image
Top movers analysis one hour before the close of the markets on 2025-11-14: top gainers and losers in today's session. ↗
November 14, 2025
Via Chartmill
News headline image
Earnings Scheduled For August 14, 2025 ↗
August 14, 2025
Via Benzinga
News headline image
Which stocks are moving on Friday? ↗
November 14, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
November 14, 2025
Via Benzinga
News headline image
Traws Pharma Reports Third Quarter 2025 Results and Business Highlights
November 13, 2025
From Traws Pharma, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
October 27, 2025
Via Benzinga
News headline image
Traws Pharma Doses First Patient with Ratutrelvir in Phase 2 COVID Studies, Expects Results by Year-End 2025
October 14, 2025
From Traws Pharma, Inc.
Via GlobeNewswire
News headline image
Traws Pharma Adds John Leaman, MD, as Independent Director and Formalizes Appointments of Two Key Executives
October 06, 2025
From Traws Pharma, Inc.
Via GlobeNewswire
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Appoints Mark Guerin as Chief Financial Officer
September 25, 2025
Via Investor Brand Network
News headline image
Annovis Appoints Mark Guerin as Chief Financial Officer
September 25, 2025
From Annovis Bio Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
September 17, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
September 05, 2025
Via Benzinga
News headline image
Traws Pharma Receives Approval to Proceed with Phase 2 COVID Studies with Ratutrelvir, Expects Results by Year-End 2025
August 18, 2025
From Traws Pharma, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
August 14, 2025
Via Benzinga
News headline image
Traws Pharma Posts Q2 Revenue Jump ↗
August 14, 2025
Via The Motley Fool
News headline image
Traws Pharma Reports Second Quarter 2025 Results and Business Highlights
August 14, 2025
From Traws Pharma, Inc.
Via GlobeNewswire
News headline image
Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
August 08, 2025
From Traws Pharma, Inc.
Via GlobeNewswire
News headline image
Cooling US Bird Flu Wave Removes Tailwind For Moderna, Novavax, CureVac, Traws Pharma ↗
July 08, 2025
Via Stocktwits
News headline image
Traws Pharma Advances Antiviral Pipeline with Multiple Regulatory Submissions
June 30, 2025
From Traws Pharma, Inc.
Via GlobeNewswire
News headline image
Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗
June 13, 2025
Via Benzinga
News headline image
MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard Surge – More Stocks Inside!
June 04, 2025
Via AB Newswire
News headline image
What's going on in today's session ↗
June 03, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
June 03, 2025
Via Benzinga

Frequently Asked Questions

Is Traws Pharma, Inc. - Common Stock publicly traded?
Yes, Traws Pharma, Inc. - Common Stock is publicly traded.
What exchange does Traws Pharma, Inc. - Common Stock trade on?
Traws Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Traws Pharma, Inc. - Common Stock?
The ticker symbol for Traws Pharma, Inc. - Common Stock is TRAW on the Nasdaq Stock Market
What is the current price of Traws Pharma, Inc. - Common Stock?
The current price of Traws Pharma, Inc. - Common Stock is 1.410
When was Traws Pharma, Inc. - Common Stock last traded?
The last trade of Traws Pharma, Inc. - Common Stock was at 01/08/26 04:00 PM ET
What is the market capitalization of Traws Pharma, Inc. - Common Stock?
The market capitalization of Traws Pharma, Inc. - Common Stock is 7.85M
How many shares of Traws Pharma, Inc. - Common Stock are outstanding?
Traws Pharma, Inc. - Common Stock has 8M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap